CRMD
CorMedix Inc.#36 · 2024BreakoutCYearly return
+115%
Peak return
+267%
Max drawdown
-48%
ADR (20 days)
+5.2%
Base
21 days / -43.3%
Prior run
+85%
Breakout volume
5.3x
Pivot
$5.34
Catalyst Analysten/Re-Rating2024-04-11Wall Street Analysts Predict a 146.21% Upside in CorMedix (CRMD): Here's What You Should KnowZacks Investment Research
Analysten- oder Re-Rating-Impuls, oft mit Momentum-Folgekaeufern.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare CRMD with the current market directly.